Why Standardisation Is the Real Product

I am Duncan Macrae, founder of Motark Enterprise, and "standardised" is one of the most common words on a botanical specification sheet, and one of the least examined. It gets printed on labels, repeated in marketing copy, and nodded along to by buyers who assume it means something specific. Often it does. Just as often, it is doing very little work at all. This piece is about what the word should mean, why it is so hard to deliver in practice, and why Motark Enterprise treats it as the actual product rather than a claim printed alongside one.

Standardisation Is Not a Marketing Word

In the botanical supply trade, "standardised" is one of the most abused terms on a specification sheet. Used properly, it means something narrow and testable: the material has been analysed against a defined marker compound, using a defined analytical method, and falls within a defined range — batch after batch, verifiably. Used loosely, it can mean almost nothing at all.

Take Tongkat Ali, standardised against eurycomanone, where the potency of the raw root varies with the age of the tree and the region it grew in. Or kanna, whose alkaloid profile shifts measurably during fermentation, so an uncontrolled fermentation produces an uncontrolled product. Bacopa's "bacoside A" turns out to be a mixture of several distinct saponins in varying ratios, which means two honest suppliers can report different numbers for reasons that are purely methodological. Moringa's polyphenol and glucosinolate content moves with climate, soil, leaf age, and drying method. Kava's entire safety conversation hinges on whether the material is a noble variety or not.

Different plants, different failure modes, but the same underlying lesson: the label alone tells a buyer almost nothing. The verification is the value.

Why the Traditional Preparation Was Never the Problem

None of this is a criticism of traditional practice. A village healer brewing bitter Tongkat Ali tea, or a Khoikhoi preparer fermenting kanna in a skin bag, was not formulating to a specification and had no need to. Variability in that context is not a defect — it is a natural consequence of working with a living plant, and the people involved understood their material intimately enough to compensate for it.

The problem arises the moment that material enters a modern supply chain. A formulator producing tens of thousands of units against a fixed specification cannot absorb the kind of variation a village preparer took for granted. They need the same potency this quarter that they had last quarter, and they need to be able to evidence it to a regulator, a retailer, and an auditor. Bridging that gap between a plant that varies and a specification that cannot is, in essence, the whole job — and it is the job Motark Enterprise exists to do.

The Part People Underestimate: This Is Specialist Laboratory Work

Here is where I, Duncan Macrae, want to be direct about how Motark Enterprise operates, because I think the industry is often vague about it in ways that do not serve buyers.

Verifying a standardised botanical extract is not something you do with a good eye and long experience. It requires high performance liquid chromatography, mass spectrometry, and the supporting infrastructure around them — reference standards, validated methods, calibration regimes, trained analysts, controlled sample handling, and documented chains of custody. That equipment is expensive to acquire and considerably more expensive to keep meaningfully accurate. Instruments drift. Reference standards expire. Methods that were fit for purpose five years ago get superseded. An HPLC system that is not being calibrated, maintained, and re-validated on a disciplined schedule is not producing data anyone should be formulating against.

On top of that sits a regulatory landscape that genuinely does not hold still. Permissible marker compounds, testing requirements, contaminant limits, novel food classifications, and labelling rules differ across markets and get revised regularly — and kava is the obvious example of a botanical whose regulatory position has shifted substantially over two decades. Keeping pace with that is not a side task. It is a full discipline in its own right.

Why Motark Enterprise Works With Third-Party Specialists

For that reason, Motark Enterprise deliberately does not pretend to do all of this in-house. We work with accredited third-party laboratory and processing partners whose entire business is maintaining that equipment, validating those methods, and tracking regulatory change across the markets our customers sell into.

I consider this a strength rather than an admission. A partner whose sole focus is analytical work will always keep instruments better calibrated, methods better validated, and regulatory knowledge more current than a business treating testing as an ancillary function. It also introduces something structurally valuable: independence. When the organisation verifying a batch is not the organisation with a commercial interest in that batch passing, the resulting certificate of analysis carries more weight — with our customers, and with their auditors.

This extends beyond testing. Motark Enterprise works through specialist manufacturing partners for raw material sourcing and processing as well, for the same reason: getting it right, batch after batch, depends on infrastructure and expertise that is a full-time discipline in its own right, not something to be bolted on as a side function. Our role is to define what each extract must be, select partners genuinely capable of meeting that specification, and stand behind the result.

What This Means for a Formulator

If you are sourcing botanical extract, the practical takeaway is straightforward: whoever supplies you should be able to answer questions that go well beyond the label. Which marker compound is this standardised against, and by which method? Who performed the analysis, and are they accredited? Is the certificate of analysis batch-specific or generic? What is the specified range, and what happens when material falls outside it? Which species, verified how? For kava specifically, which variety — and how is that established?

These are exactly the questions Motark Enterprise puts to its own manufacturing and testing partners. A partner who treats that scrutiny as reasonable is a partner worth working with. One who treats it as an inconvenience is telling you something useful before you have committed to anything.

A Boring Discipline That Matters Enormously

None of what I have described here is especially glamorous. Calibration schedules and method validation do not make for good storytelling, and they will never carry the weight of a centuries-old trade record or a naturalist's field notes. But they are the reason a plant's traditional history can be handled responsibly rather than turned into an unsupported marketing claim, and they are the difference between a botanical trade that earns trust and one that simply borrows it.

That is the standard Motark Enterprise is built around, whatever the plant. Understand what you are actually buying, verify rather than assume, and work with people who treat consistency as non-negotiable. Every single batch.

This article is offered as general commentary on supply-chain and quality-control practice. It is not a therapeutic claim about any botanical extract, and it is not regulatory advice. Anyone formulating for a specific market should consult the regulatory guidance applicable to that market and take appropriate professional advice.